In Utero Exposure to Antipsychotics
May 2011, ObGyn News, Lee S. Cohen, MD Reprinted with permission from Ob. Gyn. News Copyright by International Medical News Group, an Elsevier company Previous columns on the reproductive safety of psychiatric medications have focused on the attendant risks of fetal exposure to antidepressants, benzodiazepines, and mood stabilizers such as lithium and sodium valproate. [...]
This entry was posted on May 17, 2011 at 8:47 pm, and is filed under
atypical antipsychotics,
drugs during pregnancy,
effects of antipsychotic medications on newborns,
EPS,
FDA,
medication during pregnancy,
National Pregnancy Registry for Atypical Antipsychotics,
ObGyn News,
pregnancy,
Pregnancy Regsitry,
psychiatric disorder during pregnancy,
Psychiatric Disorders During Pregnancy,
risk of medication during pregnancy,
safety of medication during pregnancy,
women's mental health. Follow any responses to this post through
RSS 2.0. You can
leave a response or
trackback from your own site.